These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Therapeutic strategies and controversies in the treatment of multiple myeloma. Bladé J Pathol Biol (Paris); 1999 Feb; 47(2):192-8. PubMed ID: 10192888 [TBL] [Abstract][Full Text] [Related]
9. [Multiple myeloma--advances in disease biology and implications for therapy]. Chou T Gan To Kagaku Ryoho; 2001 Sep; 28(9):1206-12. PubMed ID: 11579631 [TBL] [Abstract][Full Text] [Related]
10. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT. Pitini V; Arrigo C; Aloi G; Micali C; La Gattuta G Bone Marrow Transplant; 2003 Jun; 31(11):1065; author reply 1067. PubMed ID: 12774062 [No Abstract] [Full Text] [Related]
11. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma. Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245 [TBL] [Abstract][Full Text] [Related]
12. Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma. Gorschlüter M; Ziske C; Glasmacher A; Schmidt-Wolf IG Clin Cancer Res; 2001 Aug; 7(8):2195-204. PubMed ID: 11489792 [TBL] [Abstract][Full Text] [Related]
14. [Results, failures and perspectives in therapy of multiple myeloma]. Bessmel'tsev SS; Abdulkadyrov KM Vopr Onkol; 2002; 48(2):146-52. PubMed ID: 12227061 [No Abstract] [Full Text] [Related]
15. Lenalidomide and its role in the management of multiple myeloma. Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796 [TBL] [Abstract][Full Text] [Related]
16. [Therapy of multiple myeloma]. La Verde G; Pulsoni A; Petrucci MT; Mandelli F Recenti Prog Med; 1997 Apr; 88(4):186-93. PubMed ID: 9206817 [TBL] [Abstract][Full Text] [Related]
17. [High-dose melphalan in patients with multiple myeloma]. Moreau P; Le Bonniec M; Harousseau JL Bull Cancer; 1999 Mar; 86(3):283-8. PubMed ID: 10210762 [TBL] [Abstract][Full Text] [Related]
18. [Comparative evaluation of the effectiveness of mono- and polychemotherapy programs in patients with multiple myeloma]. Abdulkadyrov KM; Bessmel'tsev SS Klin Med (Mosk); 1992; 70(9-10):57-60. PubMed ID: 1474818 [No Abstract] [Full Text] [Related]
19. Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome. Chim CS Cancer Chemother Pharmacol; 2008 Jun; 62(1):181-2. PubMed ID: 17846773 [No Abstract] [Full Text] [Related]
20. [Skeletal bone lesion and the effectiveness of Bonephos (clodronate) in the comprehensive therapy of multiple myeloma]. Bessmel'tsev SS; Abdulkadyrov KM Vopr Onkol; 1996; 42(4):12-8. PubMed ID: 8928450 [No Abstract] [Full Text] [Related] [Next] [New Search]